产品
编 号：F388593
分子式：C10H16N2O6S2
分子量：324.37
分子式：C10H16N2O6S2
分子量：324.37
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
100mg
询价
询价
结构图
CAS No: 5545-17-5
产品详情
生物活性：
N,N'-diacetyl-L-cystine (DiNAC) is the disulphide dimer of N-acetylcysteine with immunomodulating properties. N,N'-diacetyl-L-cystine is a potent, orally active modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents. N,N'-diacetyl-L-cystine also has antiatherosclerotic effects in Watanabe-heritable hyperlipidemic rabbit (WHHL) rabbits.
体内研究：
N,N'-Diacetyl-L-cystine (DiNAC; 0-973.11 μg/kg; oral administration; daily; for 12 weeks; WHHL rabbits) treatment reduces by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels.Animal Model:Male heritable hyperlipidemic rabbit (WHHL) rabbits (10-22 weeks)
Dosage:0 μg/kg, 9.73 μg/kg, or 973.11 μg/kg
Administration:Oral administration; daily; for 12 weeks
Result:Reduced by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels.
N,N'-diacetyl-L-cystine (DiNAC) is the disulphide dimer of N-acetylcysteine with immunomodulating properties. N,N'-diacetyl-L-cystine is a potent, orally active modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents. N,N'-diacetyl-L-cystine also has antiatherosclerotic effects in Watanabe-heritable hyperlipidemic rabbit (WHHL) rabbits.
体内研究：
N,N'-Diacetyl-L-cystine (DiNAC; 0-973.11 μg/kg; oral administration; daily; for 12 weeks; WHHL rabbits) treatment reduces by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels.Animal Model:Male heritable hyperlipidemic rabbit (WHHL) rabbits (10-22 weeks)
Dosage:0 μg/kg, 9.73 μg/kg, or 973.11 μg/kg
Administration:Oral administration; daily; for 12 weeks
Result:Reduced by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备